Liquids

We develop and manufacture liquid products by focusing on stable performance and reliable dose delivery.

Inner banner
Manufacturing-ready decisions

Liquids that scale consistently

For non‑sterile liquid drug products, pharmaceutical companies look for stable performance and dependable dose delivery across real‑world use conditions. Groupe PARIMA supports oral, topical, nasal, sublingual, and otic liquids by aligning formulation design, packaging, or device selection, and GMP execution, so programs scale smoothly and stay consistent.

Robust formula over shelf life

We connect formulation, in‑house analytics, and manufacturing to meet liquid product requirements for stability and solubility. 

Proven stability expertise

We build formulations for consistent performance, including solutions, emulsions, and oil‑based formats.

MICROBIOLOGICAL CONTROL

We design preservative strategies supporting non‑sterile liquids across routes of administration.

PACKAGING AND DEVICE FIT 

Align packaging components with formulation to support consistent dose delivery and user experience.

Reliable performance outcomes

We develop non-sterile liquid drug products, supported by fit-for-purpose testing to ensure consistent performance from development through scale-up.

Card 01

DEFINE THE TARGET PRESENTATION

Translate the target product profile into clear requirements for route of administration, dosing approach, and user experience, then set the CQAs.

Card 02

DESIGN THE FORMULATION STRATEGY

Select the right formulation, such as solution, emulsion, or oil, based on the solubility approach, excipient compatibility, and sensory profile. 

Card 03

PRESERVATIVE STRATEGY

Develop a preservative strategy and supporting studies, including preservative efficacy testing when applicable.

Card 04

CONFIRM PACKAGING AND DEVICE FIT

Align packaging components with formulation properties to support consistent dose delivery and practical use. 

Card 05

STANDARDIZE GMP EXECUTION

Establish a reproducible manufacturing process with in-house analytical support and an ICH-aligned stability plan.

Our Capabilities

We support liquid products with capabilities built around stable performance, reliable dose delivery, and scale-ready execution.

Oral Liquids
Oral Liquids

Support flexible dosing and patient-friendly administration through solutions and emulsions designed for stable performance, practical use, and real-world application.

  • Co-solvents, pH adjustment, or complexation aligned to the API and target profile.
  • Sweeteners, flavor systems, and bitter blockers when relevant to the product.
  • Preservative systems selected to support microbiological control and product acceptability.
Nasal Liquids
Nasal Liquids

Stable formulation performance and consistent delivery are achieved by aligning formulation, preservation strategy, and device fit to support reliable use.

  • Formulation mucoadhesion adjusted to support mucosal retention and user comfort, where applicable.
  • Approach designed to support uniform delivery across packaging design.
  • Metered-dose or non-metered packaging selected to match formulation and packaging design.
Sublingual Liquids
Sublingual Liquids

Sublingual liquids require controlled delivery and packaging that supports consistent use. We align formulation with device compatibility to ensure reliable dosing and administration.

  • Pump or spray systems aligned to formulation properties and dosing goals.
  • Formulation and process choices focused on sensorial feel and uniform delivery across actuations.
  • Preservative excipient and testing approach aligned to non-sterile requirements, including PET when applicable.
Otic liquids
Otic Liquids

Require stable formulation performance and consistent delivery through the chosen presentation. We align formulation, preservation strategy, and device fit to support reliable use.

  • Robust preservative selection and microbial control aligned to non-sterile otic use, including PET when applicable.
  • Dropper or pump selection aligned to consistent dosing expectations.
  • Excipients and formulation choices tuned to support comfortable, practical use.
Topical Liquids
Topical Liquids

Dermatologic and mucosal applications require spreadability and cosmetic acceptability. We balance performance and usability through formulation aligned with the application.

  • Excipient selection aligned to absorption goals and skin compatibility.
  • Alcohol-free and non-irritant systems developed when appropriate for sensitive sites.
  • Residue, drying time, and stability assessed under expected usage conditions.
Oil-Based Liquids
Oil-Based Liquids

Lipophilic APIs are well-suited to oil-based systems that support the delivery profile. We optimize oil selection and packaging to ensure stable performance and practical dosing.

  • Dropper bottles or soft tubes selected to support practical, controlled dosing.
  • Preservation approach aligned to the system’s composition and intended use.
  • Mineral and vegetable oil, medium-chain triglycerides, or ester-based blends selected to support stability and API compatibility.

Our Services

We align development, analytics, and GMP execution for liquid drug products to ensure stability, microbiological control, and reliable dosing.

01
Layer_1 (3)-1
Product Development

Manufacturing-ready liquid formulations, built for stability and reliable dose delivery.

02
Icons (1)-2
Analytical Services

Fit-for-purpose testing to support stability, preservation, and confident release.

03
Icons (2)-1
Manufacturing & Packaging

GMP execution and presentation fit aligned to consistent dosing through droppers, pumps, or sprays.

We make liquid performance predictable by aligning stability, preservation, and presentation fit from the start.

Resources

Explore content that helps plan non-sterile liquid drug products with clarity, from formulation strategy to scale-up execution.

Groupe PARIMA
2026/04/27
How Drug Product Formulation Works: Topical, Oral, and Nasal Liquid and Semi-Solid Dosage Forms
Groupe PARIMA
2026/03/18
How Early API Characterization Can Reduce Formulation and Scale-up Risks
Groupe PARIMA
2025/10/23
Topical 101: A Guide to Complex Dermatology Formulation Development
Groupe PARIMA
2026/04/27
How Drug Product Formulation Works: Topical, Oral, and Nasal Liquid and Semi-Solid Dosage Forms
Groupe PARIMA
2026/03/18
How Early API Characterization Can Reduce Formulation and Scale-up Risks
Groupe PARIMA
2025/10/23
Topical 101: A Guide to Complex Dermatology Formulation Development

Contact Us

Develop liquids with confidence.

Share your route of administration, and we help you align formulation, preservation, and packaging to ensure consistent performance at scale.